HGF and Hepatic fibrosis: This could be confirmed in murine fibrosis models using carbon tetrachloride (CCl4) or dimethylnitrosurea (DMN), where the injection of platelet-rich plasma (PRP) significantly reduced hepatic fibrosis by increasing fibrolytic markers such as HGF and MMPs [70,71].